logo
header-image

Psychopharmacology and Psychiatry Updates

by Psychopharmacology Institute
130 EPISODES
Yesterday
All Episodes
Antidepressants vs. Anticonvulsants for Binge Eating
Psychopharmacology Institute
Lithium Levels: Finding the Right Therapeutic Target
Psychopharmacology Institute
Antidepressants Beyond Depression: Applications in Bulimia Nervosa
Psychopharmacology Institute
Metformin and Antipsychotic-Induced Weight Gain: An Evidence-Based Solution
Psychopharmacology Institute
Monthly Injections, Long-Term Recovery: Naltrexone for OUD
Psychopharmacology Institute
Antipsychotics and Aspiration Risk
Psychopharmacology Institute
Buprenorphine, Methadone, and Naltrexone: Helping Patients with OUD Decide
Psychopharmacology Institute
Managing OUD with Buprenorphine: Clinical Pearls
Psychopharmacology Institute
Valproate Weight Gain: Do Lower Doses Help?
Psychopharmacology Institute
Methadone for Opioid Use Disorder
Psychopharmacology Institute
Clozapine and Compulsions: New Research On An Old Side Effect
Psychopharmacology Institute
Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD
Psychopharmacology Institute
Beyond Tapering: Supporting Patients Through Benzodiazepine Discontinuation
Psychopharmacology Institute
Beyond Blood Counts: Clozapine, Bowel Obstruction, and Pneumonia
Psychopharmacology Institute
Demystifying Benzodiazepine Deprescribing: Smart Approaches to Tapering
Psychopharmacology Institute
Lithium: Implications for Bone Health
Psychopharmacology Institute
Tapering with Care: Benzodiazepine Discontinuation
Psychopharmacology Institute
Dementia Risk and Vitamin D
Psychopharmacology Institute
Beyond Benzos: Strategies for Successful Deprescribing
Psychopharmacology Institute
Motherhood and Medication: LAIs for Women with Schizophrenia
Psychopharmacology Institute
Benzodiazepines in High-Risk Populations
Psychopharmacology Institute
Benzodiazepines: Understanding Physical Dependence vs. Addiction
Psychopharmacology Institute
Beyond Metformin: Probiotics and Antipsychotic Weight Gain
Psychopharmacology Institute
What Every Clinician Should Know About the Risks of Benzodiazepines
Psychopharmacology Institute
Making an Exit Plan: Navigating Antidepressant Discontinuation
Psychopharmacology Institute
Clinical Pearls for Selecting the Right Benzodiazepine
Psychopharmacology Institute
TMS for Depression: From Clinical Trials to Results
Psychopharmacology Institute
A Guide to Selecting TMS Candidates
Psychopharmacology Institute
Rethinking Clozapine Monitoring: 22 Years of Data
Psychopharmacology Institute
Understanding TMS in OCD: Evidence and Practice
Psychopharmacology Institute
Breaking Down the TRAILBLAZER-ALZ 2 Trial
Psychopharmacology Institute
Long-term Benzo Use: What The Data Really Show
Psychopharmacology Institute
Navigating TMS Side Effects: A Practical Guide
Psychopharmacology Institute
SSRIs and Anticoagulants: Navigating Bleeding Risk
Psychopharmacology Institute
Lamotrigine and the Heart: What You Need to Know
Psychopharmacology Institute
After the Last Dose: Understanding Antipsychotic Discontinuation
Psychopharmacology Institute
Understanding Lamotrigine's Cardiac Effects
Psychopharmacology Institute
Rethinking Falls: Are Sleep Medications Really to Blame?
Psychopharmacology Institute
Navigating Lamotrigine's Side Effects
Psychopharmacology Institute
Iloperidone in Bipolar Disorder: A New Treatment Option?
Psychopharmacology Institute
Lamotrigine: Pearls for Prescribing
Psychopharmacology Institute
Beyond Benzos: New Frontiers in Agitation Management
Psychopharmacology Institute
KarXT: A New Dawn in Antipsychotic Treatment
Psychopharmacology Institute
Rethinking Agitation Management: From Force to Partnership
Psychopharmacology Institute
COVID Brain Fog: Repurposing Famotidine
Psychopharmacology Institute
Beyond Restraints: De-Escalation in Behavioral Emergencies
Psychopharmacology Institute
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
Psychopharmacology Institute
Unraveling Agitation: Mania vs. Substance Use
Psychopharmacology Institute
Pushing the Boundaries: Exploring High-Dose Antipsychotics
Psychopharmacology Institute
The Psychodynamic Prescriber
Psychopharmacology Institute